Grant: Discovery Grants Program - Individual
University of Alberta
$72,000.00
Development of bacteriophages as alternatives to antibiotics
EF 2022-23
Résumé
Bacteriophages (or phages) are viruses that specifically infect and kill bacteria. Most phages are comprised of an icosahedral head containing a double-stranded DNA genome, attached to a phage tail responsible for adhering to a surface receptor on the host bacterium. During infection the phage genome is delivered to the cell interior where phage proteins are expressed. The phage tail / host cell receptor interface is thought to be one of the most specific “lock and key” interactions in the biological world, and gives phages their exquisite specificity for bacterial cells. Molecular analysis of these mechanisms can provide insight into how phages defeat their bacterial hosts, and suggest successful strategies man can utilize to combat pathogenic bacteria. With the worldwide overuse of chemical antibiotics since the mid-20th century, we have recently observed a rapid increase in the number of bacteria presenting extreme antibiotic resistance, including bacteria of the genera Burkholderia and Stenotrophomonas. Therefore, the search for alternatives to antibiotics has gained importance, and the application of or treatment with phages has demonstrated promise, not only for human infections, but also for animal and plant diseases caused by bacteria. Numerous experimental studies have established phage treatment efficacy in both agricultural and clinical settings, and recently, instances of human lives being saved from pathogenic bacteria has been documented in North America. These results suggest that with further development, phages will become a useful addition to medicines available to complement or replace traditional antibiotics. The objective of this proposal is to examine phage mechanisms of attachment to bacterial receptors, and with this knowledge, optimize phages for application against highly antibiotic resistant bacteria. To decrease the evolution of phage resistance, multiple phages with different receptors will be combined, and phages that target virulence factors will promote anti-virulence in bacteria mutating to escape phage attack. Phages can be modified using molecular biology to eliminate problematic genes / proteins, and improved by adding genes that encode proteins that enhance activity (e.g. broaden host range, penetrate biofilms). Molecular characterization of the phage receptor-binding proteins, and the bacterium's surface receptors will provide important insights into the nature of the mechanisms involved in phage:bacterium interactions. The knowledge gained through this work will create opportunities to engineer phages against pathogenic and antibiotic resistant bacteria for a variety of novel biotechnological applications, including biosensors, relevant to agriculture, industry, and healthcare.
Programme
Discovery Grants Program - Individual
Bénéficiaire
Emplacement
Alberta, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
RGPIN-2018-04355
Name nom
Dennis, Jonathan
Department département
Biological Sciences - Biological Sciences
Organization id
9
Institution établissement
University of Alberta
Province en
Alberta
Province fr
Alberta
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2022
Competition year année de concours
2018
Award amount
72000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
DISCOVERY RESEARCH
Group fr
RECHERCHE AXÉE SUR LA DÉCOUVERTE
Committee code
1501
Committee name en
Genes, Cells and Molecules
Committee name fr
Gènes, cellules et molécules
Area of application code
1201
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Life sciences (including biotechnology)
Area of application fr
Sciences de la vie (y compris biotechnologie)
Research subject code
5200
Research subject group en
Microbiology
Research subject group fr
Microbiologie
Research subject en
Microbiology
Research subject fr
Microbiologie
Installment
inst:5;6
Partie
2
Nb partie
6
Application title
Development of bacteriophages as alternatives to antibiotics
Application summary
Bacteriophages (or phages) are viruses that specifically infect and kill bacteria. Most phages are comprised of an icosahedral head containing a double-stranded DNA genome, attached to a phage tail responsible for adhering to a surface receptor on the host bacterium. During infection the phage genome is delivered to the cell interior where phage proteins are expressed. The phage tail / host cell receptor interface is thought to be one of the most specific “lock and key” interactions in the biological world, and gives phages their exquisite specificity for bacterial cells. Molecular analysis of these mechanisms can provide insight into how phages defeat their bacterial hosts, and suggest successful strategies man can utilize to combat pathogenic bacteria. With the worldwide overuse of chemical antibiotics since the mid-20th century, we have recently observed a rapid increase in the number of bacteria presenting extreme antibiotic resistance, including bacteria of the genera Burkholderia and Stenotrophomonas. Therefore, the search for alternatives to antibiotics has gained importance, and the application of or treatment with phages has demonstrated promise, not only for human infections, but also for animal and plant diseases caused by bacteria. Numerous experimental studies have established phage treatment efficacy in both agricultural and clinical settings, and recently, instances of human lives being saved from pathogenic bacteria has been documented in North America. These results suggest that with further development, phages will become a useful addition to medicines available to complement or replace traditional antibiotics. The objective of this proposal is to examine phage mechanisms of attachment to bacterial receptors, and with this knowledge, optimize phages for application against highly antibiotic resistant bacteria. To decrease the evolution of phage resistance, multiple phages with different receptors will be combined, and phages that target virulence factors will promote anti-virulence in bacteria mutating to escape phage attack. Phages can be modified using molecular biology to eliminate problematic genes / proteins, and improved by adding genes that encode proteins that enhance activity (e.g. broaden host range, penetrate biofilms). Molecular characterization of the phage receptor-binding proteins, and the bacterium's surface receptors will provide important insights into the nature of the mechanisms involved in phage:bacterium interactions. The knowledge gained through this work will create opportunities to engineer phages against pathogenic and antibiotic resistant bacteria for a variety of novel biotechnological applications, including biosensors, relevant to agriculture, industry, and healthcare.